Intermediate doses cytarabine after induction with CPX-351 for patients with secondary AML: safety and efficacy.

ABSTRACT:

SUBMITTER: Perrone S 

PROVIDER: S-EPMC12894116 | biostudies-literature | 2026 Feb

REPOSITORIES: biostudies-literature